Drug-labels.com

Xofluza: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
40 mg, 80 mg, 20 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Xofluza

Serious warnings and precautions box

What XOFLUZA is used for:

  • XOFLUZA is used to treat influenza (the flu) in patients 12 years or older who have had flu symptoms for no more than 48 hours. It is given to healthy patients or patients that are more likely to have health problems from the flu.

How XOFLUZA works:

  • XOFLUZA stops the flu virus from making more copies of itself inside of your body. This will help kill the flu virus.

The ingredients in XOFLUZA are:

Medicinal ingredients: Baloxavir marboxil

Non-medicinal ingredients: croscarmellose sodium, hypromellose, lactose monohydrate, microcrystalline cellulose, povidone, sodium stearyl fumarate, talc, titanium dioxide.

XOFLUZA comes in the following dosage forms:

Tablets, 20 mg, 40 mg, and 80 mg

Do not use XOFLUZA if:

  • you are allergic to baloxavir marboxil or any of the non-medicinal ingredients

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take XOFLUZA. Talk about any health conditions or problems you may have, including if you:

  • are pregnant, planning on becoming pregnant, or are breastfeeding. XOFLUZA was not studied

  • Some patients taking XOFLUZA have reported serious side effects including anaphylaxis (allergic reaction) and angioedema (swelling of the tissue under the skin).
  • If you experience any of these serious side effects, get immediate medical help. You should not use this medicine again.
  • For further information and symptoms, see the “Possible side effects from using XOFLUZA” section.
  • in pregnant or breastfeeding women and the risk, if any, to your baby is not known.

Other warnings you should know about:

  • XOFLUZA is only used to treat the flu caused by virus types A and type B.
  • XOFLUZA is not used for treatment after 48 hours of symptoms, or for the prevention of the flu.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with XOFLUZA:

  • Dairy products
  • Calcium-fortified beverages
  • Laxatives, antacids, and oral supplements containing iron, zinc, selenium, calcium, magnesium.

How to take XOFLUZA:

  • XOFLUZA should be taken once as a single dose.
  • Take XOFLUZA exactly as your healthcare professional tells you to take it.

Usual dose:

Patients 12 years of age and older: Your healthcare professional will determine your dose based on your weight:

Body Weight (kg)XOFLUZA dose:
40 kg to less than 80 kg

Two 20 mg tablets

OR

One 40 mg tablet

80 kg or more

Two 40 mg tablets

OR

One 80 mg tablet

Overdose:

If you think you, or a person you are caring for, have taken too much XOFLUZA, contact a healthcare professional, hospital emergency department, regional poison control centre or Health Canada’s toll-free number, 1-844 POISON-X (1-844-764-7669) immediately, even if there are no signs or symptoms.

Missed Dose:

XOFLUZA is taken as a single dose.

Possible side effects from using XOFLUZA:

These are not all the possible side effects you may feel when taking XOFLUZA. If you experience any side effects not listed here, tell your healthcare professional.

  • Hives
  • Diarrhea
  • Nausea
  • Vomiting
  • Sinus infection
  • Headache
  • Bronchitis

Serious side effects and what to do about them

Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking this drug and get immediate medical help
Only if severeIn all cases
Unknown
Anaphylaxis (Allergic Reaction): difficulty swallowing or breathing, wheezing; drop in blood pressure; feeling sick to your stomach and throwing up; hives or rash; swelling of the face, lips, tongue or throat.✓
Angioedema (swelling of tissue under the skin): difficulty breathing; swollen face, hands and feet, genitals, tongue, throat; Swelling of the digestive tract causing diarrhea, nausea or vomiting.✓
Gastrointestinal disorders (Stomach and bowel problems): bloody diarrhea or dark bloody stool.✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (canada.ca/drug-device-reporting) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store between 15-30°C, store in the original package in order to protect from moisture.

Keep out of reach and sight of children.

If you want more information about XOFLUZA:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes the Patient Medication Information by visiting the Health Canada Drug Product Database website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html; the manufacturer’s website www.rochecanada.com, or by calling 1-888-762-4388.

Date of Authorization: 2025-05-27

XOFLUZA® is a registered trademark of F. Hoffmann-La Roche AG, used under license.

©Copyright 2020-2025, Hoffmann-La Roche Limited.

Logo

Hoffmann-La Roche Limited

Mississauga, Ontario L5N 5M8

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02496372

Approved according to the text: May 27, 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Xofluza

Rx or OTC
Prescription (Rx)?
DIN 02496372, 02524163, 02496364
Schedule(s) PRESCRIPTION
Active ingredient(s) Baloxavir marboxil
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J05 Antivirals for systemic use
      1. J05A Direct acting antivirals
        1. J05AX Other antivirals
          1. J05AX25 Baloxavir marboxil
Company HOFFMANN-LA ROCHE LIMITED
Current status Marketed
Strengths and forms
DIN Strength Dosage form(s) Current status
02496372 40 MG Tablet Marketed January 15, 2026
02524163 80 MG Tablet Marketed March 5, 2025
02496364 20 MG Tablet Marketed September 25, 2025

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.